Ascletis Pharma Inc. (ASCLF)
USD 0.81
(-12.29%)
USD 0.81
(-12.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.99 Million CNY | 205.26% |
| 2022 | -24.69 Million CNY | -163.03% |
| 2021 | 39.17 Million CNY | 266.71% |
| 2020 | -23.49 Million CNY | -118.91% |
| 2019 | 124.28 Million CNY | -19.27% |
| 2018 | 153.94 Million CNY | 189.36% |
| 2017 | 53.2 Million CNY | 61.34% |
| 2016 | 32.97 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 25.99 Million CNY | 205.26% |
| 2023 Q4 | -2.5 Million USD | 0.0% |
| 2023 Q2 | 4.79 Million USD | 0.0% |
| 2022 FY | -24.69 Million CNY | -163.03% |
| 2022 Q2 | 1.7 Million USD | 0.0% |
| 2022 Q4 | -8.79 Million USD | 0.0% |
| 2021 Q2 | -2.06 Million USD | 0.0% |
| 2021 Q4 | 6.25 Million USD | 0.0% |
| 2021 FY | 39.17 Million CNY | 266.71% |
| 2020 FY | -23.49 Million CNY | -118.91% |
| 2020 Q2 | 1.7 Million USD | 0.0% |
| 2020 Q4 | -7.9 Million USD | 0.0% |
| 2019 Q4 | 8.56 Million USD | 0.0% |
| 2019 FY | 124.28 Million CNY | -19.27% |
| 2019 Q2 | 7.16 Million USD | 0.0% |
| 2018 Q2 | 61.26 Million CNY | 19.98% |
| 2018 FY | 153.94 Million CNY | 189.36% |
| 2018 Q1 | 51.06 Million CNY | 0.0% |
| 2017 Q2 | 13.3 Million CNY | -0.01% |
| 2017 FY | 53.2 Million CNY | 61.34% |
| 2017 Q1 | 13.3 Million CNY | 0.0% |
| 2016 FY | 32.97 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioxytran, Inc. | -8285.00 USD | 313799.457% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -73.278% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -165.367% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -39441.748% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -122.023% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 78.179% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 76205.417% |
| Marizyme, Inc. | 457.7 Thousand USD | -5578.367% |
| Genus plc | 178.7 Million USD | 85.456% |
| Pharming Group N.V. | 220.1 Million USD | 88.192% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -41667.107% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -6236.474% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 236372.727% |
| ContraFect Corporation | -154 Thousand USD | 16976.623% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -33758.34% |
| IMV Inc. | -962.29 Thousand USD | 2800.827% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 6807.079% |
| ONE Bio Corp. | 20.12 Million USD | -29.14% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 35.453% |
| Mesoblast Limited | -35.16 Million USD | 173.902% |
| MultiCell Technologies, Inc. | 49.32 USD | -52696574.777% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 8.016% |
| Genscript Biotech Corporation | 409.55 Million USD | 93.654% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -837746.551% |
| Biomind Labs Inc. | -15.42 Thousand USD | 168603.631% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 2376.685% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -37028.571% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 21017.337% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 524938.449% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 52080.0% |
| Arch Therapeutics, Inc. | -2439.00 USD | 1065700.656% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -18398.221% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -53049.284% |
| Q BioMed Inc. | -8988.00 USD | 289263.329% |
| GB Sciences, Inc. | -624.00 USD | 4165164.103% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 30311.094% |
| CSL Limited | 7.56 Billion USD | 99.656% |
| Agentix Corp. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 41.408% |
| Enzolytics Inc. | 30.7 Thousand USD | -84535.925% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -5287.277% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 26752.31% |
| argenx SE | 1.1 Billion USD | 97.655% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 200.744% |
| HST Global, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 12495292.308% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 5151.408% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 293573.351% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -4109.698% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 31096.196% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -2530.617% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -170.419% |
| Kadimastem Ltd | -630.13 Thousand USD | 4224.493% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | -68.494% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 219702.873% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 53955.239% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -14620.208% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -14620.208% |
| Affymax, Inc. | 1.35 Million USD | -1815.052% |
| Mobile Lads Corp. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -464.019% |
| CytoDyn Inc. | -29 Thousand USD | 89720.69% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -5675.004% |
| SYBLEU INC | 11.69 Thousand USD | -222112.722% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 8234.407% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 7067.828% |
| Neutra Corp. | 14.33 Thousand USD | -181204.499% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 31795.122% |
| PureTech Health plc | -1.6 Million USD | 1721.335% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 2695.792% |
| IXICO plc | 3.27 Million USD | -694.801% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 3844.957% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 1551.145% |
| CSL Limited | 7.7 Billion USD | 99.663% |
| Cellectis S.A. | 18 Thousand USD | -144288.889% |